A theme involving the development of surrogate powder measurement, 3D printers, single-use automation and aseptic processing technologies for the manufacture of high-potency, biologic and sterile pharmaceuticals, and their commercialization as iFactory and labor-saving systems. The company is also pursuing patent acquisition for medium-molecule and biologic pharmaceuticals.